Watch and wait after neoadjuvant treatment in rectal cancer: comparison of outcomes in patients with and without a complete response at first reassessment in the International Watch & Wait Database (IWWD)
Open Access
- 27 March 2023
- journal article
- research article
- Published by Oxford University Press (OUP) in British Journal of Surgery
- Vol. 110 (6) , 676-684
Abstract
In rectal cancer, watch and wait for patients with a cCR after neoadjuvant treatment has an established evidence base. However, there is a lack of consensus on the definition and management of a near-cCR. This study aimed to compare outcomes in patients who achieved a cCR at first reassessment versus later reassessment. This registry study included patients from the International Watch & Wait Database. Patients were categorized as having a cCR at first reassessment or at later reassessment (that is near-cCR at first reassessment) based on MRI and endoscopy. Organ preservation, distant metastasis-free survival, and overall survival rates were calculated. Subgroup analyses were done for near-cCR groups based on the response evaluation according to modality. A total of 1010 patients were identified. At first reassessment, 608 patients had a cCR; 402 had a cCR at later reassessment. Median follow-up was 2.6 years for patients with a cCR at first reassessment and 2.9 years for those with a cCR at later reassessment. The 2-year organ preservation rate was 77.8 (95 per cent c.i. 74.2 to 81.5) and 79.3 (75.1 to 83.7) per cent respectively (P = 0.499). Similarly, no differences were found between groups in distant metastasis-free survival or overall survival rate. Subgroup analyses showed a higher organ preservation rate in the group with a near-cCR categorized exclusively by MRI. Oncological outcomes for patients with a cCR at later reassessment are no worse than those of patients with a cCR at first reassessment.Keywords
Funding Information
- European Union’s Horizon 2020 (857894)
This publication has 26 references indexed in Scilit:
- Magnetic resonance imaging for clinical management of rectal cancer: Updated recommendations from the 2016 European Society of Gastrointestinal and Abdominal Radiology (ESGAR) consensus meetingEuropean Radiology, 2017
- A watch-and-wait approach for locally advanced rectal cancer after a clinical complete response following neoadjuvant chemoradiation: a systematic review and meta-analysisThe Lancet Gastroenterology & Hepatology, 2017
- Optimal fractionation of preoperative radiotherapy and timing to surgery for rectal cancer (Stockholm III): a multicentre, randomised, non-blinded, phase 3, non-inferiority trialThe Lancet Oncology, 2017
- Long-term Outcome of an Organ Preservation Program After Neoadjuvant Treatment for Rectal CancerJNCI: Journal of the National Cancer Institute, 2016
- Watch-and-wait approach versus surgical resection after chemoradiotherapy for patients with rectal cancer (the OnCoRe project): a propensity-score matched cohort analysisThe Lancet Oncology, 2016
- A new paradigm for rectal cancer: Organ preservationEuropean Journal of Surgical Oncology, 2015
- Assessment of Clinical Complete Response After Chemoradiation for Rectal Cancer with Digital Rectal Examination, Endoscopy, and MRI: Selection for Organ-Saving TreatmentAnnals of Surgical Oncology, 2015
- Nonoperative Management of Rectal Cancer With Complete Clinical Response After Neoadjuvant TherapyAnnals of Surgery, 2012
- Operative Versus Nonoperative Treatment for Stage 0 Distal Rectal Cancer Following Chemoradiation TherapyAnnals of Surgery, 2004
- A note on quantifying follow-up in studies of failure timeControlled Clinical Trials, 1996